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in the near future, face disciplinary hearings convened by the
HPCSA, and in several cases this may well result in the
disruption of practices of individuals who are in fact
committed to honest and ethical practice.
It is therefore with great concern that I note that the issue of
receiving kickbacks has not been comprehensively debated.
The HPCSA has launched into wholesale investigation of
individuals who it has alleged have received kickbacks, which
is immediately equated with a practice tainted by ‘perverse
incentives’. This assumption is fundamentally flawed, if for
one reason alone — practitioners may receive remuneration
from a source which provides a service to their patients
without this influencing their practice profile (the manner in
which they actually practise). Clearly the misdemeanour lies
with the remuneration becoming a perverse incentive with
regard to the modus of practice rather than receiving the
payment per se.
As regard the issue of perverse incentives, many situations
exist across the spectrum of practice which may incorporate
this temptation. These include use of owned or co-owned
apparatus for special investigations, the own supply of various
surgical implants, as well as the basic dispensing of own drug
stocks. Yet we trust in the integrity of the practitioner not to be
tempted by the perverse incentive to over-service for monetary
gain. The same rationale should be applied to individuals who
have received payment from a practice/institution servicing
their patients — the misdemeanor is in the practice profile
being influenced perversely by the incentive rather than
receiving the payment per se.
The evaluation of whether a practice profile has been
influenced by perverse incentives can only be performed by the
representative body of a given specialty/group in the form of
peer review. Only then can evidence be led relating to possible
professional misconduct.
I believe that further debate is urgently required in respect
of this issue. It is imperative that SAMA, as the representative
body of the profession as well as the individual
specialist/group representative societies, engage the HPCSA on
this matter. Once comprehensively discussed, specific
guidelines should be formulated which would apply across the
full spectrum of practice as discussed above, with clear
definition regarding remuneration on the one hand and
perverse incentivised profiles on the other.
With regard to my personal situation I maintain innocence
in respect of all allegations made and reserve my rights.
I R Weinberg
Linksfield Park Clinic
Johannesburg
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Cannabis use in South Africa
To the Editor: In response to my initial article1 on the subject,
Pretorius and Naude2 imply that I: (i) do not view cannabis as
harmful; and (ii) support the legalisation of cannabis. On the
contrary, as indicated in my article,1 I see cannabis as being
associated in some users with several adverse health
consequences, including respiratory disease, adverse effects on
adolescent development, cognitive impairment, exacerbation of
psychosis, and psychomotor impairment — many of the effects
they have highlighted in their letter. However, I have sought to
list those with the strongest empirical support rather than
adverse effects that might be confounded by other causal
factors. Far from calling for the legalisation of cannabis, I called
for decriminalisation of cannabis use (instituting civil rather
than criminal penalties for cannabis possession). Legalisation is
an entirely different thing! Decriminalising cannabis possession
could potentially free up hundreds of thousands of rands spent
per day on law enforcement and criminal justice processing of
users of cannabis (not dealers). This could more profitably be
used to fund a public health response preventing cannabis use
among children and adolescents, and focusing on cannabis
users at high risk for harm or having patterns of use that are
harmful.
Charles Parry
Alcohol and Drug Abuse Research Group
Medical Research Council
Tygerberg, W Cape
1. Parry CDH. Critical issues in the debate on decriminalisation or legalisation of cannabis in
South Africa (Forum). S Afr Med J 2002; 92: 697-698.
2. Pretorius E, Naudé H. Cannabis use in South Africa (Briewe). S Afr Med J 2002; 92: 927-928
Child rape
To the Editor: The reaction of Professor Davies1 to our report
on child rape2 airs an atmosphere of despair.
Since we live in a country where the majority of hospital
admissions are trauma-related, we feel strongly that the
medical profession also has a major role to play in the
prevention of trauma. However, before we are able to change
anything, we will have to know exactly what is happening in
our society and report this accurately. Child sexual abuse is a
very sensitive issue and bound to evoke strong personal
emotions. Several reports have been quoted indicating that (at
least) one in four females have been sexually abused before the
age of 18 years. This is a clear indication that awful things do
happen in our environment. Without awareness of what is
happening, changes are unlikely to occur and the situation is
unlikely to improve.
Based on our research we have made presentations to the
Parliamentary Task Team on Sexual Abuse against Children.
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